$1.55
▼ -2.5% Today
as of Jul 22, 16:50 ET
Last 30 days
Recent Press Releases & News
Imunon Says Ovarian Cancer Drug Trial Preliminary Results Show Deeper Antitumor Response
IMUNON Reports Positive Phase 2 MRD Clinical Data for IMNN-001, Demonstrating the Successful Overcoming of Historical IL-12 Safety Barriers in Frontline Ovarian Cancer
Exclusive: Imunon Says Lead Drug Continues To Show Promise in Advanced Ovarian Cancer Patients
Overview
52-week range
$2.05
$28
0% of range
Avg surprise (last 3)
+24.9%
Avg reaction (last 2)
+0.7%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 12, 2026 | Mar/2026 | $-0.84 | $-0.99 | +15.2% | -200.0% | -1.1% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-1.16 | — | — | — | — | financials |
| Tue Aug 5, 2025 | Jun/2025 | $-2.15 | $-3.55 | +39.4% | — | — | earnings |
| Mon May 12, 2025 | Mar/2025 | $-0.28 | $-0.35 | +20.0% | — | +2.5% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-3.76 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-7.64 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.52 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.37 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.61 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 4, 2026 | Jun/2026 | OTHER | -$0.94 | -$1.87 | +49.7% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-4M | — | $-3M | $-3M | $-4M | — | $-5M | $-5M |
| Net income | $-4M | — | $-3M | $-3M | $-4M | — | $-5M | $-5M |
| EPS (diluted) | $-0.84 | — | $-1.16 | $-2.15 | $-3.15 | — | $-3.76 | $-7.64 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $5M | $9M | $5M | $5M | $3M | $6M | $10M | $5M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $7M | $11M | $7M | $7M | $5M | $8M | $13M | $8M |
| Total assets | $8M | $12M | $9M | $9M | $7M | $10M | $14M | $10M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $5M | $5M | $5M | $6M | $6M | $5M | $6M | $6M |
| Total equity | $3M | $7M | $4M | $3M | $452,028 | $4M | $8M | $4M |
Implied volatility — last 90 days
No IV snapshots yet for IMNN.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.